Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Research on the function of HGH1 in breast cancer remains lacking.
Methods: TCGAand GEO (GSE45827) datasets investigated discrepancies in HGH1 expression in BC. An aggregate of 106 clinical samples were gathered through immunohistochemistry, KM curves were drawn for prognostic analysis, and the function of HGH1 of BC was predicted. Finally, the effects of HGH1 knockdown on MDA-MB-231 and MCF-7 BC cells were verified via CCK8, invasion, wound healing and colony formation assays.
Results: HGH1 is highly expressed in BC and is linked to unfavorable prognosis. HGH1 overexpression is connected to keratinization and the cell cycle and is closely related to ER and PR expression and tumor stage in BC patients. Knocking down HGH1 in BC cells inhibited the viability, invasion and migration.
Conclusion: Knockdown of HGH1 in breast cancer cell lines can inhibit the viability, invasion and migration of tumor cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657051 | PMC |
| http://dx.doi.org/10.1080/19336918.2024.2442349 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
HGH1 Promotes Breast Cancer Progression Through the PI3K/AKT/NF-κB Signaling Pathway: Potential Role for Prognosis and Targeted Therapy.
Breast Cancer (Dove Med Press)
April 2025
Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, People's Republic of China.
Introduction: Previous studies have shown that the HGH1 gene is associated with poor prognosis in a variety of cancers, but its specific function and molecular mechanism in the pathological process of breast cancer remain unclear.
Methods: The relationship between expression of HGH1 and overall survival in BC patients was analyzed. Enrichment analysis of HGH1-related signaling pathways and immune infiltration was performed.
Knockdown of HGH1 in breast cancer cell lines can inhibit the viability, invasion and migration of tumor cells.
Cell Adh Migr
December 2025
Department of Rehabilitation, School of Nursing, Jilin University, Changchun, China.
Background: Research on the function of HGH1 in breast cancer remains lacking.
Methods: TCGAand GEO (GSE45827) datasets investigated discrepancies in HGH1 expression in BC. An aggregate of 106 clinical samples were gathered through immunohistochemistry, KM curves were drawn for prognostic analysis, and the function of HGH1 of BC was predicted.
The role of HGH1 in breast cancer prognosis: a study on immune response and cell cycle.
BMC Cancer
September 2024
Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, Hunan, 415000, China.
Background: Breast cancer (BRCA) remains to be among the main causes of cancer-associated mortality in women globally. HGH1 homolog (HGH1) has been reported to be associated with tumor immunity. However, the function of HGH1 in BRCA remains unclear.
View Article and Find Full Text PDFComprehensive analysis of the prognostic and immunological roles of HGH1 in breast cancer.
Asian J Surg
December 2024
Department of Oncology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China. Electronic address:
NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through mC methylation.
Breast Cancer Res
June 2024
Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshedong Rd, Zhengzhou, Henan, 450052, China.
Article Synopsis
- Scientists studied a protein called NSUN2 that is important for adding a chemical tag (mC) to RNA, which is linked to breast cancer development.
- They discovered that NSUN2 affects a gene called HGH1, which helps cancer grow, by changing the way the gene works and interacts with proteins.
- Their research showed that blocking NSUN2 can slow down breast cancer growth, highlighting its role in this disease.